Kaposi Sarcoma

What is Kaposi Sarcoma?

Kaposi sarcoma (KS) is a type of cancer that develops from the cells lining the lymph or blood vessels. It often appears as tumors on the skin or mucosal surfaces, such as inside the mouth, but it can also affect other areas like the lymph nodes, lungs, or digestive tract. KS is caused by human herpesvirus 8 (HHV-8) infection, also known as Kaposi sarcoma-associated herpesvirus (KSHV).

There are several types of Kaposi sarcoma, each associated with different groups of people and varying in severity:

  • Classic Kaposi Sarcoma: Typically affects older men of Mediterranean or Eastern European descent. It progresses slowly and is often limited to the skin.
  • Epidemic (AIDS-related) Kaposi Sarcoma: Occurs in individuals with HIV/AIDS. This form is more aggressive and can affect multiple organs.
  • Endemic (African) Kaposi Sarcoma: Common in parts of sub-Saharan Africa, this type can affect younger individuals and may be more aggressive than the classic form.
  • Iatrogenic (Transplant-related) Kaposi Sarcoma: Occurs in people who have received organ transplants and are on immunosuppressive medications. Reducing or changing these medications can sometimes improve the condition.

Risk Factors

Kaposi sarcoma (KS) is a type of cancer that forms in the lining of blood and lymph vessels. It is associated with various risk factors, including:

  • Human Herpesvirus 8 (HHV-8): The primary risk factor for Kaposi sarcoma is infection with HHV-8, also known as Kaposi sarcoma-associated herpesvirus (KSHV).
  • Immunosuppression: Individuals with weakened immune systems are at a higher risk for KS. This includes people with HIV/AIDS, organ transplant recipients, and those on immunosuppressive drugs.
  • HIV/AIDS: Kaposi sarcoma is more common and aggressive in individuals with HIV/AIDS due to the significant immunosuppression caused by the virus.
  • Geographic Location: KS is more prevalent in certain geographic regions, particularly in sub-Saharan Africa, parts of the Mediterranean, and among specific populations such as Ashkenazi Jews and Mediterranean men.
  • Sexual Behavior: Men who have sex with men (MSM) are at a higher risk of KS due to a higher prevalence of HHV-8 infection in this group.
  • Genetic Factors: Some genetic factors may influence susceptibility to KS, although the specifics are not well understood.
  • Older Age: Classic KS typically occurs in older adults, particularly those of Mediterranean or Eastern European descent.
  • Male Gender: Men are more frequently affected by KS than women.

These risk factors contribute to the development and progression of Kaposi sarcoma. Preventative measures focus on reducing HHV-8 transmission and managing immunosuppression, especially in high-risk populations.

Preventative Measures

Kaposi Sarcoma (KS) is a type of cancer that often affects people with weakened immune systems, such as those with HIV/AIDS. Preventative measures focus largely on maintaining a healthy immune system and reducing risk factors. Here are some key preventative strategies:

  • HIV Management
    • Antiretroviral Therapy (ART): For individuals with HIV, adhering to ART can maintain a strong immune system and significantly reduce the risk of developing KS.
    • Regular Monitoring: Regular check-ups and monitoring of CD4 counts and viral loads to ensure the immune system remains robust.
  • Preventing HIV Transmission
    • Safe Sex Practices: Using condoms and other barriers to reduce the risk of HIV transmission.
    • Pre-exposure Prophylaxis (PrEP): For high-risk individuals, taking PrEP can reduce the risk of contracting HIV.
    • Avoid Sharing Needles: Ensuring sterile needles for drug use or other medical purposes.
  • Human Herpesvirus 8 (HHV-8)
    • Screening and Awareness: Although there is no routine screening for HHV-8, being aware of the risks, especially for those with HIV, can help in early detection and management.
  • General Immune System Health
    • Healthy Lifestyle: Eating a balanced diet, exercising regularly, and avoiding smoking can help maintain a healthy immune system.
    • Regular Medical Check-ups: Regular health screenings to catch and manage any potential issues early.
  • Environmental and Behavioral Factors
    • Reduce Exposure: Minimizing exposure to environmental risk factors such as contaminated blood or organ transplants from HHV-8 positive donors.
    • Education and Awareness: Educating at-risk populations about KS and its risk factors to promote early detection and preventative measures.
  • Vaccination Research
    • Future Vaccines: Ongoing research into vaccines for HHV-8 might offer additional preventive measures in the future.

Implementing these strategies can help reduce the risk of developing Kaposi Sarcoma, especially for those at higher risk due to HIV/AIDS or other immune system-related conditions.

Individuals with multiple risk factors or who notice unusual skin lesions should seek medical evaluation by a GW Cancer Center cutaneous oncologist. Early detection and appropriate treatment are crucial in managing Kaposi sarcoma.